Disclosed herein are compositions of CPG15-2 and methods for treating
conditions of excessive cell death, such as neurological conditions,
using such compositions. Compounds that inhibit the activity of CPG15-2
are also disclosed herein for the treatment of conditions of undesirable
cell survival, such as cancer.